ZACHARY ORME: Open Payments
NPI 1548880818 · CHESTER, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 28 payments from 13 companies in 2025. Trend: 2023 $178 · 2024 $471 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $96 |
| Sumitomo Pharma America, Inc. | 4 | $71 |
| Dexcom, Inc. | 2 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| Exact Sciences Corporation | 3 | $56 |
| SANOFI PASTEUR INC. | 2 | $51 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| ABBVIE INC. | 1 | $29 |
| Pharmacosmos Therapeutics Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: AIRSUPRA, GEMTESA, Dexcom G6 Transmitter, JARDIANCE, The Cologuard Plus Collection Kit, CREON, BEYFORTUS, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE.
Industry payments across IL — which companies pay providers there.
